These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles. Kang CY, Luo L, Wainberg MA, Li Y. Biol Chem; 1999 Mar 15; 380(3):353-64. PubMed ID: 10223338 [Abstract] [Full Text] [Related]
9. Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies. Chakraborty K, Durani V, Miranda ER, Citron M, Liang X, Schleif W, Joyce JG, Varadarajan R. Biochem J; 2006 Nov 01; 399(3):483-91. PubMed ID: 16827663 [Abstract] [Full Text] [Related]
10. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein. Peet NM, McKeating JA, de Souza JB, Roitt IM, Delves PJ, Lund T. Virology; 1998 Nov 10; 251(1):59-70. PubMed ID: 9813203 [Abstract] [Full Text] [Related]
11. Anti-cellular antibodies in sera from vaccinated macaques can induce complement-mediated virolysis of human immunodeficiency virus and simian immunodeficiency virus. Spear GT, Takefman DM, Sullivan BL, Landay AL, Jennings MB, Carlson JR. Virology; 1993 Aug 10; 195(2):475-80. PubMed ID: 8337824 [Abstract] [Full Text] [Related]